TapewireFind a company

person · Reporting owner

SCOTT SAMUEL C III

Disclosed activity across 4 companies

Tapewire entity
15972
SEC CIK
0001202862

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ABBOTT LABORATORIESABT · Entity 2314DirectorApril 26, 2019April 30, 2019
Bank of New York Mellon CorpBK · Entity 2899DirectorFebruary 11, 2022February 15, 2022
GCM Grosvenor Inc.GCMG · Entity 2006DirectorSeptember 30, 2026October 02, 2026
Motorola Solutions, Inc.MSI · Entity 2943DirectorMay 14, 2018May 16, 2018

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ABBOTT LABORATORIES

Report date April 26, 2019 · Filed April 30, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common shares without par valueSEC Table I · non-derivativeDirect40,053 Reported balance After 2019-04-26 transaction · row 1
1 source row

Row 1 · 2019-04-26 · Grant · Acquired 2,241 · Balance 40,053

F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $78.06 · Expires 2029-04-25Direct10,146 Reported balance After 2019-04-26 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2019-04-26 · Grant · Acquired 10,146 · Balance 10,146

F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Filing footnotes · ownership attribution and instrument terms

F1: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F2: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Bank of New York Mellon Corp

Report date February 11, 2022 · Filed February 15, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect21,710.965 Reported balance After 2022-02-11 transaction · row 1
1 source row

Row 1 · 2022-02-11 · Grant · Acquired 100.097 · Balance 21,710.965

F1: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

Filing footnotes · ownership attribution and instrument terms

F1: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

GCM Grosvenor Inc.

Report date September 30, 2026 · Filed October 02, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect129,575 Reported balance After 2026-09-30 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-30 · Grant · Acquired 5,722 · Balance 129,575

F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Class A Common Stock of the Issuer.

F2: This award of RSUs was granted pursuant to the Issuer's Amended and Restated 2020 Incentive Award Plan, in lieu of quarterly cash compensation at the election of the Reporting Person, and is fully vested as of the date of grant. Shares of Class A Common Stock in settlement of vested RSUs will be delivered upon the earliest to occur of the Reporting Person's "separation from service" from the Issuer, a "change in control event" of the Issuer or the Reporting Person's death or disability.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Class A Common Stock of the Issuer.

F2: This award of RSUs was granted pursuant to the Issuer's Amended and Restated 2020 Incentive Award Plan, in lieu of quarterly cash compensation at the election of the Reporting Person, and is fully vested as of the date of grant. Shares of Class A Common Stock in settlement of vested RSUs will be delivered upon the earliest to occur of the Reporting Person's "separation from service" from the Issuer, a "change in control event" of the Issuer or the Reporting Person's death or disability.

Motorola Solutions, Inc.

Report date May 14, 2018 · Filed May 16, 2018

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Motorola Solutions, Inc. - Common StockSEC Table I · non-derivativeDirect43,804.8474 Reported balance After 2018-05-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2018-05-14 · Grant · Acquired 1,770 · Balance 43,804.8474

F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended.

F2: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock.

Motorola Solutions, Inc. - Common StockSEC Table I · non-derivativeIndirectBy Trust640 Reported balance Holding disclosure · report date 2018-05-14 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 640

F3: Samuel C. Scott III is the trustee of a Money Purchase Pension Plan Trust for Samuel C. Scott III.

Filing footnotes · ownership attribution and instrument terms

F1: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended.

F2: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock.

F3: Samuel C. Scott III is the trustee of a Money Purchase Pension Plan Trust for Samuel C. Scott III.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 11, 2017 Filed Aug 15, 2017 20:34 UTC Bank of New York Mellon Corp BK · Entity 2899 GrantCommon Stock 75.804 $49.74 $3,770.64
Disclosure

SEC source: 0001209191-17-048981 · doc4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,748.783

F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

Read SEC document
May 16, 2017 Filed May 18, 2017 20:33 UTC Motorola Solutions, Inc. MSI · Entity 2943 GrantMotorola Solutions, Inc. - Common Stock 2,271 $0.00 $0.00
Disclosure

SEC source: 0001578512-17-000011 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,218.099

F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities and Exchange Act of 1934, as amended.

F2 · balance_after: Includes shares acquired through the reinvestment of dividends and Deferred Stock Units received pursuant to dividend equivalent rights which were credited to the reporting person when and as dividends were paid on Motorola Solutions, Inc. common stock.

Read SEC document
May 12, 2017 Filed May 16, 2017 20:46 UTC Bank of New York Mellon Corp BK · Entity 2899 GrantCommon Stock 67.198 $44.23 $2,972.30
Disclosure

SEC source: 0001209191-17-032717 · doc4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,672.979

F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

Read SEC document
April 28, 2017 Filed May 2, 2017 21:10 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantOption (right to buy) · Derivative 18,148 $0.00 Strike: $43.64 $0.00
Disclosure

SEC source: 0001179110-17-006411 · edgar.xml · derivative · entry 2

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,148

Underlying: Common shares · 18,148 shares

Expires 2027-04-27

F2 · security: Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Read SEC document
April 28, 2017 Filed May 2, 2017 21:10 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,437 $0.00 $0.00
Disclosure

SEC source: 0001179110-17-006411 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,867

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2017 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 21, 2017 Filed Apr 25, 2017 20:39 UTC Bank of New York Mellon Corp BK · Entity 2899 GrantDeferred Stock Units · Derivative 2,780 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-17-028130 · doc4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,010.8722

Underlying: Common Stock · 2,780 shares

Expires not disclosed

F1 · derivative.exercise_price: 1-for-1.

F3 · price: N/A.

F2 · derivative.exercise_date: The deferred stock units vest on the earlier of the date of the Corporation's 2018 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning of the 30th day following grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvested in additional deferred stock units.

F2 · derivative.expiration_date: The deferred stock units vest on the earlier of the date of the Corporation's 2018 Annual Meeting of Shareholders or one year from the grant date. Vested deferred stock units are payable in shares of Common Stock either in a lump sum or, if the grantee has so elected, in annual installments, in each case beginning of the 30th day following grantee's termination of service as a director of the Corporation. Deferred stock units pay dividend equivalents which are reinvested in additional deferred stock units.

Read SEC document
February 10, 2017 Filed Feb 14, 2017 22:44 UTC Bank of New York Mellon Corp BK · Entity 2899 GrantCommon Stock 68.362 $43.29 $2,959.33
Disclosure

SEC source: 0001209191-17-010613 · doc4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,605.781

F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

Read SEC document
November 10, 2016 Filed Nov 14, 2016 22:48 UTC Bank of New York Mellon Corp BK · Entity 2899 GrantCommon Stock 66.576 $44.26 $2,946.69
Disclosure

SEC source: 0001209191-16-149845 · doc4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,537.419

F1 · shares: Dividend reinvestment in Stock Account of Deferred Compensation Plan for Non-Employee Directors of The Bank of New York Company, Inc.

Read SEC document
April 29, 2016 Filed May 3, 2016 21:27 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,799 $0.00 $0.00
Disclosure

SEC source: 0001179110-16-023682 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,430

F1 · shares: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 24, 2015 Filed Apr 28, 2015 21:14 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,793 $0.00 $0.00
Disclosure

SEC source: 0001179110-15-006746 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,631

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 25, 2014 Filed Apr 29, 2014 21:09 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,535 $0.00 $0.00
Disclosure

SEC source: 0001179110-14-007327 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,838

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 26, 2013 Filed Apr 30, 2013 21:09 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 3,097 $0.00 $0.00
Disclosure

SEC source: 0001179110-13-007410 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,303

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 27, 2012 Filed May 1, 2012 21:08 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,819 $0.00 $0.00
Disclosure

SEC source: 0001179110-12-007447 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,206

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 29, 2011 Filed May 3, 2011 21:24 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,167 $0.00 $0.00
Disclosure

SEC source: 0001179110-11-007236 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,387

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
April 23, 2010 Filed Apr 27, 2010 22:23 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,108 $0.00 $0.00
Disclosure

SEC source: 0001179110-10-007458 · edgar.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,220

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
December 31, 2009 Filed Jan 5, 2010 22:36 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 555 $53.99 Strike: $0.00 $29,964.45
Disclosure

SEC source: 0001179110-10-000404 · edgar.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,602

Underlying: Common shares · 555 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2009 Filed Oct 2, 2009 20:12 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 606 $49.47 Strike: $0.00 $29,978.82
Disclosure

SEC source: 0001179110-09-014053 · edgar.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,009

Underlying: Common Shares · 606 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2009 Filed Jul 1, 2009 21:11 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock Equivalent Units · Derivative 605 $47.04 Strike: $0.00 $28,459.20
Disclosure

SEC source: 0001179110-09-010343 · edgar.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,363

Underlying: Common Shares · 605 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 24, 2009 Filed Apr 28, 2009 22:27 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 2,465 $0.00 $0.00
Disclosure

SEC source: 0001104659-09-026812 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,112

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 2009 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2009 Filed Apr 2, 2009 23:35 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 534 $47.70 Strike: $0.00 $25,471.80
Disclosure

SEC source: 0001104659-09-022381 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,723

Underlying: Common Shares · 534 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2008 Filed Jan 5, 2009 22:04 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 477 $53.37 Strike: $0.00 $25,457.49
Disclosure

SEC source: 0001104659-09-000351 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,167

Underlying: Common Shares · 477 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2008 Filed Oct 2, 2008 21:02 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 442 $57.58 Strike: $0.00 $25,450.36
Disclosure

SEC source: 0001104659-08-061721 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,672

Underlying: Common Shares · 442 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2008 Filed Jul 2, 2008 23:46 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 481 $52.97 Strike: $0.00 $25,478.57
Disclosure

SEC source: 0001104659-08-043860 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,216

Underlying: Common Shares · 481 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
April 25, 2008 Filed Apr 30, 2008 00:12 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,917 $0.00 $0.00
Disclosure

SEC source: 0001104659-08-028079 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,647

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document
March 31, 2008 Filed Apr 2, 2008 22:30 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 462 $55.15 Strike: $0.00 $25,479.30
Disclosure

SEC source: 0001104659-08-022157 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,723

Underlying: Common Shares · 462 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
December 31, 2007 Filed Jan 2, 2008 23:11 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 454 $56.15 Strike: $0.00 $25,492.10
Disclosure

SEC source: 0001104659-08-000233 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,253

Underlying: common shares · 454 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
September 30, 2007 Filed Oct 3, 2007 00:09 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 475 $53.62 Strike: $0.00 $25,469.50
Disclosure

SEC source: 0001104659-07-072702 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 795

Underlying: common shares · 475 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Read SEC document
June 30, 2007 Filed Jul 3, 2007 18:33 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantStock equivalent units · Derivative 317 $53.55 Strike: $0.00 $16,975.35
Disclosure

SEC source: 0001104659-07-052113 · a4.xml · derivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317

Underlying: common shares · 317 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

Read SEC document
May 30, 2007 Filed May 31, 2007 19:29 UTC ABBOTT LABORATORIES ABT · Entity 2314 PurchaseCommon shares without par value 6,000 $56.26 $337,560.00
Disclosure

SEC source: 0001104659-07-044338 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,730

Read SEC document
April 27, 2007 Filed May 1, 2007 22:20 UTC ABBOTT LABORATORIES ABT · Entity 2314 GrantCommon shares without par value 1,730 $0.00 $0.00
Disclosure

SEC source: 0001104659-07-034480 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,730

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.